Page 116 - Haematologica Vol. 109 - July 2024

ARTICLE - MUD versus haplo PT-CY stem cell transplantation in children with AML A. Ruggeri et al.
with acute leukemia. Blood. 2018;132(24):2594-2607.
13. Symons HJ, Zahurak M, Cao Y, et al. Myeloablative
haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults. Blood Adv. 2020;4(16):3913-3925.
14. Bolaños-Meade J, Hamadani M, Wu J, et al. Post- transplantation cyclophosphamide-based graft-versus-host disease prophylaxis. N Engl J Med. 2023;388(25):2338-2348.
15. Saglio F, Berger M, Spadea M, et al. Haploidentical HSCT with post transplantation cyclophosphamide versus unrelated donor HSCT in pediatric patients affected by acute leukemia. Bone Marrow Transplant. 2021;56(3):586-595.
16. Srinivasan A, Raffa E, Wall DA, et al. Outcome of haploidentical peripheral blood allografts using post-transplantation cyclophosphamide compared to matched sibling and unrelated donor bone marrow allografts in pediatric patients with hematologic malignancies: a single-center analysis. Transplant Cell Ther. 2022;28(3):158.e1-158.e9.
17. Hong KT, Park HJ, Kim BK, An HY, Choi JY, Kang HJ. Post- transplantation cyclophosphamide-based haploidentical versus matched unrelated donor peripheral blood hematopoietic stem cell transplantation using myeloablative targeted busulfan- based conditioning for pediatric acute leukemia. Transplant Cell Ther. 2022;28(4):195.e1-195.e7.
18. Berger M, Lanino E, Cesaro S, et al. Feasibility and outcome of haploidentical hematopoietic stem cell transplantation with post-transplant high-dose cyclophosphamide for children and adolescents with hematologic malignancies: an AIEOP-GITMO retrospective multicenter study. Biol Blood Marrow Transplant. 2016;22(5):902-909.
19. Ruggeri A, Galimard JE, Paina O, et al. Outcomes of unmanipulated haploidentical transplantation using post- transplant cyclophosphamide (PT-Cy) in pediatric patients with acute lymphoblastic leukemia. Transplant Cell Ther. 2021;27(5):424.e1-424.e9.
20. Ruggeri A, Labopin M, Ciceri F, Mohty M, Nagler A. Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP-EBMT analysis on patients with AML in remission. Bone Marrow Transplant. 2016;51(4):610-611.
21. Martino R, Romero P, Subirá M, et al. Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. Bone Marrow Transplant. 1999;24(3):283-287.
22. Jagasia MH, Greinix HT, Arora M, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group Report. Biol Blood Marrow Transplant. 2015;21(3):389-401.
23. Willemze AJ, Geskus RB, Noordijk EM, Kal HB, Egeler RM, Vossen JM. HLA-identical haematopoietic stem cell transplantation for acute leukaemia in children: less relapse with higher biologically effective dose of TBI. Bone Marrow Transplant. 2007;40(4):319-327.
24. Peters C, Matthes-Martin S, Poetschger U, et al. Stem-cell transplantation in children with acute lymphoblastic leukemia: a prospective international multicenter trial comparing sibling donors with matched unrelated donors-The ALL-SCT-BFM-2003
trial. J Clin Oncol. 2015;33(11):1265-1274.
25. Saarinen-Pihkala UM, Gustafsson G, Ringdén O, et al. No
disadvantage in outcome of using matched unrelated donors as compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukemia in second remission. J Clin Oncol. 2001;19(14):3406-3414.
26. Gu Z, Wang L, Yuan L, et al. Similar outcomes after haploidentical transplantation with post-transplant cyclophosphamide versus HLA-matched transplantation: a meta-analysis of case-control studies. Oncotarget. 2017;29;8(38):63574-63586.
27. Shaw PJ, Kan F, Ahn KW, et al. Outcomes of pediatric bone marrow transplantation for leukemia and myelodysplasia using matched sibling, mismatched related, or matched unrelated donors. Blood. 2010;116(20):4360-4367.
28. Leung W, Campana D, Yang J, et al. High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood. 2011;118(2):223-230.
29. Passweg JR, Baldomero H, Chabannon C, et al. Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021;56(7):1651-1664.
30. Shah RM. Contemporary haploidentical stem cell transplant strategies in children with hematological malignancies. Bone Marrow Transplant. 2021;56(7):1518-1534.
31. Algeri M, Merli P, Locatelli F, Pagliara D. The role of allogeneic hematopoietic stem cell transplantation in pediatric leukemia. J Clin Med. 2021;10(17):3790.
32. Bertaina A, Merli P, Rutella S, et al. HLA-haploidentical stem cell transplantation after removal of αb+ T and B cells in children with nonmalignant disorders. Blood. 2014;124(5):822-826.
33. Merli P, Algeri M, Li Pira G, et al. Alpha/beta T-cell and B-cell depletion HLA-haploidentical hematopoietic stem cell transplantation is an effective treatment for children/young adults with acute leukemia. Blood. 2018;132(Suppl 1):2169.
34. Bashey A, Zhang MJ, McCurdy SR, et al. Mobilized peripheral blood stem cells versus unstimulated bone marrow as a graft source for T-cell–replete haploidentical donor transplantation using post-transplant cyclophosphamide. J Clin Oncol. 2017;35(26):3002-3009.
35. Jaiswal SR, Chakrabarti A, Chatterjee S, et al. Haploidentical peripheral blood stem cell transplantation with post- transplantation cyclophosphamide in children with advanced acute leukemia with fludarabine-, busulfan-, and melphalan- based conditioning. Biol Blood Marrow Transplant. 2016;22(3):499-504.
36. Pérez-Martínez A, Ferreras C, Pascual A, et al. Haploidentical transplantation in high-risk pediatric leukemia: a retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for Hematopoietic Transplantation (GETH). Am J Hematol. 2020;95(1):28-37.
37. Shelikhova L, Ilushina M, Shekhovtsova Z, et al. αb T cell- depleted haploidentical hematopoietic stem cell transplantation without antithymocyte globulin in children with chemorefractory acute myelogenous leukemia. Biol. Blood Marrow Transplant. 2019;25(5):e179-e182.
Haematologica | 109 July 2024
2130